Target
Bromodomain-containing protein 4 [44-164]
Ligand
BDBM425464
Substrate
n/a
Meas. Tech.
Alphascreen Binding Assay
IC50
<1000±n/a nM
Citation
 Zhang, JBuell, JChan, KIbrahim, PNLin, JPham, PShi, SSpevak, WWu, GWu, J Heterocyclic compounds and uses thereof US Patent  US10519177 Publication Date 12/31/2019 
Target
Name:
Bromodomain-containing protein 4 [44-164]
Synonyms:
BRD4 | BRD4_HUMAN | Bromodomain-containing protein 4 (aa 44-164) | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14412.06
Organism:
Homo sapiens (Human)
Description:
BRD4-BD1 (44-164)
Residue:
121
Sequence:
NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINEL
  
Inhibitor
Name:
BDBM425464
Synonyms:
4-[1-(benzenesulfonyl)-6-(3,5- dimethylisoxazol-4-yl)pyrrolo[3,2- b]pyridin-3-yl]benzoic acid | US10519177, Compound P-0371
Type:
Small organic molecule
Emp. Form.:
C25H19N3O5S
Mol. Mass.:
473.5
SMILES:
Cc1noc(C)c1-c1cnc2c(cn(c2c1)S(=O)(=O)c1ccccc1)-c1ccc(cc1)C(O)=O
Structure:
Search PDB for entries with ligand similarity: